Sundar PichaiSundar Pichai earned $164M in 2023
B

Alexander Hardy

CEO of BioMarin Pharmaceuticals

Education

B.A. from the University of Cambridge; M.B.A. from the University of Michigan’s Ross School of Business

Field of Expertise

Healthcare & Life Sciences - Biotechnology

Economy Sector

Healthcare

Current Tenure

1 year 2 months (Dec 2023 - Present)

Previous Experience

Chief Executive Officer of Genentech, Inc.; Head of Global Product Strategy at Roche; various leadership roles at Genentech and Novartis.

Alexander Hardy is the President and CEO of BioMarin Pharmaceuticals, a leader in biotechnology, since December 1, 2023. He has over 30 years of experience in the global healthcare and biotechnology sectors, most recently serving as CEO of Genentech, a...

Year

2023

Total Compensation

$1.99M

Salary

$1.05M

Board Justification

The compensation philosophy aims to attract and retain executive talent necessary to advance the business and increase stockholder value, with a strong emphasis on performance-based compensation.

Bonus

$900.00K

Board Justification

Signing bonus as a 'make whole' component for potential forfeited bonus at his prior employer due to the timing of the transition late in the year.

Other

$40.22K

Board Justification

Includes reimbursement of legal expenses in connection with the review of his employment agreement and imputed income associated with life insurance premium payments.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2023 as Mr. Hardy was appointed CEO effective December 1, 2023, and did not receive any performance-based equity awards for 2023.

Performance Metrics

Performance metrics for 2023 were not applicable to Mr. Hardy as he was appointed CEO on December 1, 2023.